Efficacy, Safety, and Tolerability ng Etravirine With and without Darunavir/Ritonavir o Raltegravir in Treatment-Experienced Patient: Pagsusuri ng Etravirine Early Access Program sa United States. Journal of Acquired Immune Deficiency Syndrome, 53(5): 614-618.
May-akda:
Appelbaum J, Bellman P, Gathe J, Gottlieb MS, Hoogstoel A, Laleari J, Nijs S, Ryan R, Sension M, Towner W, Van Solingen-Ristea R, Witek J, Wohlfeiler M
Gumagamit ang website na ito ng cookies upang mapabuti ang iyong karanasan. Ipagpalagay namin na ok ka dito, ngunit maaari kang mag-opt out kung gusto mo. [cookie_settings] [cookie_button]